Author name: admin1

Michael Mooney: Nutrition and HIV Activist That Helped Thousands

Michael Mooney’s Life TRANSCRIPT Hi. We are going to mute everybody during the recorded part of this memorial, and then we’ll open it up when we start telling stories. So, thank you for sharing this time with my sister Kathy and me. I wanted to tell you the story of my brother’s life, and as […]

Michael Mooney: Nutrition and HIV Activist That Helped Thousands Read More »

HIV health wellness hormones

HIV and Hormones

Low testosterone is associated with poor health status in men with HIV Use of Testosterone and Anabolic Steroids in Patients Who Have HIV Thread: Longitudinal Changes over 10 years in Free Testosterone … Are persons with HIV worthy of cancer prevention diagnoses and … How to Decrease HIV related belly fat accumulation When to start nandrolone (Decadurabolin) when

HIV and Hormones Read More »

belly fat loss

How to Decrease HIV Related Belly Fat Accumulation

In the mid-90s with the advent of the first antiretroviral (AVR) drug combination therapies, Kaposi’s sarcoma (KS) lesions and lipodystrophy (wasting away of body fat) rapidly faded from public consciousness as signs of HIV infection. Only to be replaced by another symptom that can powerfully impact the health and appearance and health of the HIV

How to Decrease HIV Related Belly Fat Accumulation Read More »

Probiotic Visbiome improves gut barrier function in patients with HIV

“Probiotic supplementation improved the physical and immunological integrity of the intestinal mucosal barrier in HIV-1-positive patients being treated with antiretroviral therapy, according to new research.   The researchers sought to evaluate the effects of a high potency multistrain probiotic — marketed in the U.S. as Visbiome (ExeGi Pharma) and Vivomixx in Europe — on intestinal

Probiotic Visbiome improves gut barrier function in patients with HIV Read More »

New HIV Drugs in the Pipeline- 2017: CROI Review by Dr Pablo Tebas

Gilead presented some data about a new capsid formation inhibitor (GS-CA1), a total new drug class that looks incredibly powerful in vitro (6) [ CROI: Discovery of Novel Potent HIV Capsid Inhibitors with Long-Acting Potential.] These compounds block the capsid formation during maturation and early after entry. They do not have cross resistance with other

New HIV Drugs in the Pipeline- 2017: CROI Review by Dr Pablo Tebas Read More »

ibalizumab HIV

Ibalizumab: First Long Acting HIV Treatment Available Now Via Expanded Access

No one can deny that many patients can now suppress their HIV with effective antiretrovirals (ARVs) that cause fewer side effects. However, a vulnerable and often forgotten minority of people are still struggling with multi-drug resistant HIV (MDR-HIV) while they anxiously wait for access to lifesaving ARVs that would finally control their viral replication. Although

Ibalizumab: First Long Acting HIV Treatment Available Now Via Expanded Access Read More »

Aerobic Exercise Increases Cognition and Brain Volume in HIV+ People

Background: HIV infected (HIV+) individuals are now reaching an advanced age, through stable treatment with highly active anti-retroviral therapy (HAART). However, HIV and aging are still risk factors for cognitive decline and neuropathologic deterioration seen in magnetic resonance imaging (MRI). Healthy lifestyle factors such as regular exercise may provide benefits to HIV+ individuals. Few studies

Aerobic Exercise Increases Cognition and Brain Volume in HIV+ People Read More »

HIV Lipodystrophy Update: Interview with Researcher Dr. Grace McComsey

HIV Lipodystrophy Update: Interview with Researcher Dr. Grace McComsey Dr. Grace McComsey has been involved in HIV research for 16 years, 12 of those as an NIH-funded principal investigator. Her work has focused on the investigations on lipodystrophy and metabolic complications in HIV. Her work was paramount in showing the link between nucleoside inhibitor-induced mitochondrial

HIV Lipodystrophy Update: Interview with Researcher Dr. Grace McComsey Read More »